Gladys Nunez
Director Amgen Ventures
Gladys Nunez
Amgen
Director Amgen Ventures
Gladys Nunez, Director Amgen Ventures, joined Amgen in 1997 and leads investment diligence and strategy for Amgen’s corporate venture group including the R&D Seed Fund. As part of portfolio management activities, she is a board observer on several portfolio companies including Obsidian Therapeutics, Kernal Bio, Immunoscape, Feldan Therapeutics, and Celsius. Based in Amgen’s Cambridge, Ma site she is a member of the site senior leadership team and supports the local outreach/startup network strategy.
Prior to joining Amgen Ventures in 2014, Gladys spent 12 years in Amgen’s External R&D group prospecting and negotiating external alliances. Prior to joining Amgen’s Business Development organization, Gladys worked 8 years in R&D, concurrent between Amgen and AstraZeneca. Gladys holds an MSc in Biochemical Pharmacology from the University of Southampton in England, and BSc from Marist College in Pre-Med.
As an active member of the Mass Bio community, she is board member and treasurer of Latinos in Bio, a pioneering non-profit working to empower and amplify the social capital of Latinx professionals in the life science industry. She is also a member of Healthcare Businesswomen’s Association supporting women’s entrepreneurial development and increasing presence of women in venture capital careers.